Psychiatrist-led Care
Treatment-Resistant Depression Care in Sugar Land and Houston, TX
If two or more antidepressants have not worked, the next step is a fresh, thorough evaluation, not another rushed prescription. We re-examine the diagnosis, optimize medication, and add augmentation or interventional referral when appropriate. Care is led by Dr. Shehram Majid, a board-certified psychiatrist, in Sugar Land, across the Greater Houston area, and online in Texas.
Meet your Psychiatrist
When depression has not responded to the first or second medication, the most valuable thing a psychiatrist can offer is a careful second look. A re-examined diagnosis. A clear, stepwise plan. And honest options when standard medications have not worked. That is how Dr. Majid built CIP Psychiatry.
Dr. Majid is a board-certified psychiatrist and the founder of CIP Psychiatry. He has treated depression at every level of severity, including the patients other treatments have not reached. His training spans inpatient, outpatient, emergency, and Veterans Affairs psychiatry, so he is comfortable with complex medication histories and the careful work of optimizing a plan. He leads a psychiatrist-led team and meets often with the nurse practitioners who handle day-to-day visits, which keeps the same standard for every patient with hard-to-treat depression.
Dr. Shehram Majid, MD
Psychiatrist for Treatment-Resistant Depression in Sugar Land and Houston
Signs
Signs Your Depression May Be Treatment-Resistant
Depression may be treatment-resistant when it has not improved after at least two antidepressants taken at an adequate dose for an adequate length of time. Common signs include partial response, relief that faded, lingering low mood, and side effects without benefit. These are the patterns we hear most often.
Antidepressants not working
Two or more medications tried at a full dose for long enough, with little or no lasting relief.
Partial response only
Some improvement, but never a full return to feeling like yourself, with symptoms that linger.
Relief that faded
A medication that helped at first and then seemed to stop working over time.
Loss of interest
Work, relationships, and activities you once enjoyed still feel out of reach.
Side effects without benefit
Tolerating medication side effects without the improvement that should justify them.
Partial response
Symptoms improve but do not fully lift. Partial response is common and treatable, and it often calls for optimizing the current medication or adding a second agent rather than starting over.
Recurrent episodes
Depression that keeps coming back, even after periods of feeling better.
Persistent low mood
Sadness, emptiness, or a flat feeling that has continued for months despite treatment.
Doubt about the diagnosis
A growing sense that something about the original diagnosis or plan was not quite right.
Non-response
Little or no change after an adequate trial. Non-response is a signal to re-examine the diagnosis and consider a different class, an augmentation strategy, or pharmacogenomic-guided selection.
These are general patterns, not rules. Treatment-resistant depression is identified through a full history, not a single appointment. If your depression has not improved despite treatment, a fresh psychiatric evaluation is worthwhile. If you are in crisis, call 911, or call or text 988.
What counts as TRD
Understanding Treatment-Resistant Depression
Treatment-resistant depression is major depression that has not responded to at least two adequate antidepressant trials. Several situations mimic it, including pseudo-resistance, misdiagnosed bipolar depression, and unaddressed medical contributors. Telling them apart is the first job of a careful evaluation.
Treatment-resistant depression
Major depression that has not responded adequately to at least two antidepressant trials of sufficient dose and duration. This is the situation where optimization, augmentation, and interventional referral come into play.
Misdiagnosed bipolar depression
Depression that resists antidepressants because the underlying condition is on the bipolar spectrum. Here the treatment changes entirely, which is why we screen for it.
Unaddressed contributors
Thyroid problems, sleep disorders, chronic pain, substance use, or another psychiatric condition can keep depression from lifting until they are treated too.
Pseudo-resistance
Depression that has not improved because of too low a dose, too short a trial, missed doses, or a medication never given a fair chance. This is common and is fixed by correcting the treatment, not escalating it.
Chronic and recurrent depression
Persistent depressive disorder or repeated episodes that wear a person down over years. These respond to a long-term, relapse-focused plan.
Difficult-to-treat depression
A broader term for depression that needs more than a standard approach, where the goal shifts toward sustained management and quality of life.
| Question | Pseudo-resistance | True treatment resistance |
|---|---|---|
| Dose and duration | Too low, or too short | Adequate dose for an adequate trial |
| Adherence | Doses often missed | Taken consistently as prescribed |
| Diagnosis | May be incomplete or off | Confirmed major depression |
| Best next step | Correct the trial | Optimize, augment, or refer for interventional options |
Why a fresh evaluation matters
Why a Fresh Evaluation Comes First
When antidepressants have not worked, the most common reason is not that depression is untreatable. It is that something in the picture has been missed. A trial that was too short or too low a dose. An undiagnosed bipolar pattern. A thyroid or sleep problem. Another condition layered underneath. A fresh evaluation is how those things come to light.
Our process starts by re-examining the diagnosis and the full treatment history, not just the current symptoms. We review every medication tried, the dose, how long it was taken, what helped, and what the side effects were. That detailed history is what separates true treatment resistance from a plan that simply has not been optimized yet.
A second psychiatric opinion has real value here. Looking at a complex depression with fresh eyes often surfaces an option that has not been tried, or a contributor that has not been addressed. The goal is a plan matched to what is actually driving the depression, not another round of the same approach.
How We Treat Treatment-Resistant Depression
Treatment Path
Treatment-resistant depression is treated in steps, each one chosen for your history. The goal is full remission and lasting stability, not just a small improvement on top of the medication you already take.
-
1
Re-examine the diagnosis and history
We start with a comprehensive psychiatric evaluation and a detailed medication review. We confirm the diagnosis, screen for bipolar spectrum features and other contributors, and map out every prior trial so the next step is informed by what has already been tried.
-
2
Optimize the current medication
Often the fastest gain is making the current plan work properly: adjusting the dose into an effective range, allowing an adequate trial length, and addressing side effects and adherence. Many cases labeled resistant respond once the medication is truly optimized.
-
3
Augmentation and class changes
When optimization is not enough, we consider evidence-based next steps: adding an augmenting agent such as a second-generation antipsychotic or a thyroid hormone strategy, combining medications thoughtfully, or switching to a different antidepressant class. Each choice is explained, with the rationale and the monitoring plan.
-
4
Pharmacogenomic-guided selection and brief supportive therapy
For patients who have not responded to several medications, we offer GeneSight genetic testing, which can add information about how your body may process certain psychiatric medications. Brief supportive psychotherapy is woven into the 25-minute medication visit, and when fuller, standalone therapy is needed we coordinate with therapists in our referral network. It is not a stand-alone therapy.
-
5
Interventional referral and long-term management
When appropriate, we coordinate referrals for interventional and neuromodulation options, such as TMS or ECT, with clinicians who provide them. We stay involved across the long term, because hard-to-treat depression does best with steady follow-up, relapse prevention, and a plan that adjusts as you do.
An honest note on scope: CIP Psychiatry is an outpatient practice. We provide evaluation, medication optimization, augmentation, and pharmacogenomic-guided care, and we coordinate referrals for interventional treatments rather than delivering them in-house. If your depression needs a higher level of care, we will say so and help connect you to it.
Strategies
Medication Strategies for Treatment-Resistant Depression
Medication strategies for treatment-resistant depression include optimizing the current antidepressant, switching class, augmenting with a second-generation antipsychotic or thyroid hormone, and pharmacogenomic-guided selection. Which one fits depends on your diagnosis, prior trials, side-effect tolerance, and how you respond.
Antidepressant optimization
Adjusting the dose into an effective range and allowing an adequate trial, often within the SSRI or SNRI classes, before deciding a medication has failed.
Class switching
Moving to a different antidepressant class when an adequate trial has not helped, matched to your symptom pattern and history.
Augmentation with a second-generation antipsychotic
Adding a low-dose agent to boost the response to an antidepressant, an evidence-based step in resistant cases, with monitoring built in.
Pharmacogenomic-guided selection
GeneSight testing can add information about how you may process certain psychiatric medications, most useful after several medications have not worked.
Other augmentation strategies
Approaches such as thyroid hormone augmentation or thoughtful medication combinations, selected by history and how you respond.
Interventional referral
Coordinated referral for neuromodulation options, such as TMS or ECT, when medication strategies have not been enough.
What to expect on the timeline: Antidepressant changes usually take four to six weeks to show their effect, and up to twelve weeks for a full response, so we resist switching too soon. Augmentation can work faster in some cases. The goal is full remission, not partial relief. Follow-ups run about 25 minutes, close together while we adjust, then spaced out as you stabilize.
Every medication conversation includes the rationale, the expected timeline, and the monitoring plan.
Remission
What Recovery From Resistant Depression Can Look Like
Depression that has resisted treatment can still get better. With a fresh plan and steady follow-up, many patients who had lost hope reach real remission. Progress usually comes in stages.
Getting the plan right
Once the diagnosis is confirmed and the medication is optimized or augmented, symptoms that had been stuck often begin to move.
Reaching remission
The goal is not partial relief but a full return toward feeling like yourself, with energy, interest, and sleep recovering together.
Staying well
Relapse prevention and regular visits protect the remission you worked to reach, and let us adjust early if symptoms start to return.
Recovery is rarely a straight line, and remission does not always come on the first new plan. For most patients it comes from a stepwise approach and a psychiatrist who stays with them. We track your progress at each visit and adjust as needed.
Free Depression & Treatment-Response Self-Check
Answer a few questions about your depression over the past two weeks, then two about how past medications have worked for you. This self-check can help you and a psychiatrist see whether your depression may be treatment-resistant. It is private and is not a diagnosis. If you are in crisis, call or text 988 or call 911.
For each item, choose how often it has been true for you over the past two weeks.
How to Read Your Depression Score
Threshold
When to Seek a Second Opinion for Depression
There is no benefit to waiting years for depression to lift on its own. If you are looking for a treatment-resistant depression psychiatrist in Sugar Land or Houston, or simply a depression specialist near you, the deciding factor is a thorough re-evaluation and a stepwise plan, not marketing. We see patients from Sugar Land and across the Greater Houston area, we are accepting new patients, and we are in network with nine major plans.
Consider an evaluation if:
✓ You have tried two or more antidepressants without enough relief
✓ A medication helped at first and then seemed to stop working
✓ You improved partly but never fully returned to feeling like yourself
✓ You are tolerating side effects without the benefit that should come with them
✓ Your depression keeps coming back after periods of feeling better
✓ You suspect the original diagnosis or plan may not have been right
✓ You want a fresh, second psychiatric opinion on a complex depression
If you are in crisis
If you or someone you know is in crisis, unsafe, or having thoughts of harming themselves or others, call 911, or call or text 988 (the Suicide and Crisis Lifeline), or go to your nearest emergency room. CIP Psychiatry is an outpatient practice and is not an emergency service.
Our Approach
Why Choose CIP Psychiatry for Treatment-Resistant Depression in Sugar Land and Houston
Six things we want patients and families to know before the first visit.
Psychiatrist-led team
Most patients are seen by a nurse practitioner on our psychiatrist-led team. Dr. Shehram Majid stays involved in every patient's care and meets with the team often, so your plan follows the same standards.
Same care team across visits
You see the same care team each time. The clinicians who know your history are the ones who adjust your plan over time.
Fresh diagnostic look
A re-examination of the diagnosis and the full treatment history, including screening for bipolar features and other contributors that can make depression resist treatment.
Coordinated interventional referral
When medication strategies are not enough, we coordinate referrals for neuromodulation options such as TMS or ECT with clinicians who provide them.
Stepwise medication strategy
Optimization first, then augmentation, class changes, and pharmacogenomic-guided selection, with each step explained and monitored.
Long-term, remission-focused care
A model built around reaching full remission and protecting it, not settling for partial relief on top of a plan that is not working.
Payment
Insurance and Self-Pay for Treatment-Resistant Depression Care
In-network coverage
We are in network with the plans below, so most patients pay only their standard copay or coinsurance. We verify your insurance in writing and share your estimated copay before your first visit. If we are out of network, we can give you a superbill for possible reimbursement.
Out of Network and Self-Pay Options
Self-pay is open to patients who are uninsured, or whose plan we do not accept.
Rates are flat by visit length:
$250 for the 50-minute diagnostic intake
$200 for the 25-minute follow-up
Genetic pharmacogenomic testing is billed separately. Ask us about a Good Faith Estimate before scheduling.
Telehealth
Online Treatment-Resistant Depression Care Across Texas
The comprehensive evaluation, medication reviews, optimization and augmentation visits, and the brief supportive therapy in each visit all work well online. The standards are the same online and in person, so care stays steady for patients in Houston and across Texas who cannot always reach our Sugar Land office.
Online care has limits worth knowing. You must be in Texas during your visit, since your provider is licensed there. Some steps, such as genetic testing and any referred interventional treatment, are arranged locally. And online care is not for emergencies. If someone is in crisis or having thoughts of self-harm, in-person or emergency care matters more than convenience. Call 911, or call or text 988.
| Visit element | In-person | Online |
|---|---|---|
| Comprehensive evaluation | Preferred | Available |
| Medication optimization and follow-up | Available | Standard |
| Augmentation monitoring | In office | Standard |
| Genetic testing | Arranged locally | Arranged locally |
| Interventional treatment | By referral | By referral |
FREQUENTLY ASKED QUESTIONS
Frequently Asked Questions About Treatment-Resistant Depression
-
Treatment-resistant depression, or TRD, generally refers to major depressive disorder that has not responded adequately to at least two antidepressant trials taken at an adequate dose for an adequate length of time. The first step in addressing it is confirming the diagnosis and reviewing exactly what has been tried.
-
Through a comprehensive psychiatric evaluation that re-examines the diagnosis, reviews every prior medication, dose, and trial length, and screens for contributors such as bipolar features, thyroid problems, sleep disorders, and other conditions. The diagnosis comes from that history, not from a questionnaire.
-
There are several reasons. The dose may be too low or the trial too short, the diagnosis may be incomplete, an underlying bipolar pattern may be present, or another medical or psychiatric condition may be in the way. Sometimes a medication that helped earlier loses effect over time. A fresh evaluation sorts out which is happening.
-
The next step is not simply another prescription. We re-examine the diagnosis, optimize the current medication, and consider augmentation, a class change, or pharmacogenomic-guided selection. When medication strategies are not enough, we coordinate referral for interventional options.
-
Yes. Depression that has resisted treatment is common and very treatable. With a confirmed diagnosis, an optimized plan, and a stepwise approach, many patients who had lost hope reach full remission. The goal is not partial relief but a real return to feeling like yourself.
-
Options include optimizing the current antidepressant, switching classes, augmentation with a second-generation antipsychotic or other strategies, pharmacogenomic-guided selection with GeneSight/Genomind testing, and coordinated referral for neuromodulation options such as TMS or ECT when appropriate. Brief supportive therapy is part of each visit, with fuller therapy coordinated when needed.
-
A second opinion is worthwhile if you have tried two or more medications without enough relief, if a medication stopped working, if you only partly improved, or if you suspect the diagnosis was not right. Fresh eyes on a complex depression often surface an option that has not been tried.
-
Yes. The evaluation, medication optimization, augmentation monitoring, and brief supportive therapy all work through secure telehealth. You need to be located in Texas during the session. GeneSight testing and any referred interventional treatment are arranged locally.
SERVICE AREA
Treatment-Resistant Depression Care in Other Texas Cities
CIP Psychiatry serves patients across Texas through in-person Sugar Land visits and telehealth. If you want a treatment-resistant depression psychiatrist nearby, the city pages are below.
TRD Treatment in Katy, TX
Telehealth and travel-friendly options for Katy families
TRD Treatment in Stafford, TX
Closest in-person location is Sugar Land, ten minutes away
TRD Treatment in Missouri City, TX
Same care team, no commute into central Houston
TRD Treatment in Richmond, TX
In-person and telehealth options
TRD Treatment in Pearland, TX
Telehealth across Pearland, in-person nearby in Sugar Land
Depression that has not responded yet is not depression that cannot respond.
With a fresh evaluation and a stepwise, remission-focused plan, many patients who had tried everything finally get better. In-person appointments in Sugar Land, serving the Greater Houston area, and online across Texas.
Prefer to speak with someone instead?
Call/Text us at (281) 500-8416 or email us at info@cipclinic.com